NLTX Historical Earnings image   This NLTX historical earnings page last updated 8/11/2022
NLTX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/9/2022NA
Q1 20225/9/2022NA
Q4 20213/1/2022NA
Q3 202111/4/2021NA
Q2 20218/5/2021NA
Q1 20215/12/2021NA
Q4 20203/25/2021NA
Q3 202011/9/2020NA
Q2 20208/12/2020NA
Q1 20205/6/2020NA
Q4 20193/12/2020NA
Q3 201911/13/2019NA
Q2 20197/31/2019NA
Q1 20195/7/2019NA
Q4 20183/7/2019NA
Q3 201811/7/2018NA
Q2 20188/8/20180.03B
Q1 20185/8/2018NA
Q4 20173/12/2018NA
Q3 201711/8/2017NA
Q2 20178/8/2017NA
Q1 20175/9/2017NA
Q4 20163/9/2017NA
Q3 201611/9/2016NA
Q2 20168/4/2016NA
Q1 20165/10/2016NA
Q4 20153/14/2016NA
Q3 201511/10/2015NA
Q2 20158/6/2015NA
Q1 20155/12/2015NA
NLTX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/9/2022-0.280
Q1 20225/9/2022-0.280
Q4 20213/1/2022-0.270
Q3 202111/4/2021-0.280
Q2 20218/5/2021-0.270
Q1 20215/12/2021-0.270
Q4 20203/25/2021-0.230
Q3 202011/9/2020-0.190
Q2 20208/12/2020-0.200
Q1 20205/6/2020-0.180
Q4 20193/12/2020-0.060
Q3 201911/13/2019-0.440
Q2 20197/31/20190.000
Q1 20195/7/2019-0.090
Q4 20183/7/2019-0.200
Q3 201811/7/2018-0.64
Q2 20188/8/20180.12
Q1 20185/8/2018-0.62
Q4 20173/12/2018-0.69
Q3 201711/8/2017-0.5
Q2 20178/8/2017-0.59
Q1 20175/9/2017-0.36
Q4 20163/9/2017-0.48
Q3 201611/9/2016-0.46
Q2 20168/4/2016-0.63
Q1 20165/10/2016-0.39
Q4 20153/14/2016-0.27
Q3 201511/10/2015-0.43
Q2 20158/6/2015-0.44
Q1 20155/12/2015-0.6
Quotes delayed 20 minutes

Email EnvelopeFree NLTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Neoleukin Therapeutics (NLTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NMTC Historical Earnings
NMTR Historical Earnings
NOTV Historical Earnings
NOVN Historical Earnings
NPCE Historical Earnings
NRBO Historical Earnings
NRC Historical Earnings
NRIX Historical Earnings
NSTG Historical Earnings
NTLA Historical Earnings
What was the record high NLTX historical earnings result?
In terms of earnings or revenue, what is the best NLTX historical earnings result that Neoleukin Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest NLTX historical earnings result was set in Q2 2018, when Neoleukin Therapeutics posted results of 0.12/share. The most successful revenue quarter within our data set was Q2 2018 when Neoleukin Therapeutics reported revenue of 0.03B.

What was the lowest Neoleukin Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest NLTX has reported, and when?

✔️Accepted answer: Within our data set, the lowest NLTX historical earnings result was set in Q4 2017, when Neoleukin Therapeutics posted results of -0.69/share. The smallest revenue quarter within our data set was Q2 2022 when Neoleukin Therapeutics reported revenue of NA.

On this page we presented the NLTX historical earnings date information for Neoleukin Therapeutics. Reviewing that NLTX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2018, when NLTX posted gaap of 0.12/share. Meanwhile the lowest NLTX historical earnings result was in Q4 2017, when NLTX posted gaap of -0.69/share. Moving to Neoleukin Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2018 when NLTX reported 0.03B in revenue, while the smallest revenue quarter was Q2 2022 when NLTX reported NA in revenue.

For self directed investors doing their due diligence on NLTX or any other given stock, their research can benefit from looking into all of the Neoleukin Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Neoleukin Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for NLTX. Thanks for visiting, and the next time you need to research NLTX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: MBIS Historical Stock Prices, DKS Insider Buying, Top Ten Hedge Funds Holding HJLI.

 

NLTX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.